[1] 唐神结, 李亮, 高文, 等. 中国结核病年鉴. 北京: 人民卫生出版社, 2016.
[2] Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev, 2015, 264(1):182-203.
[3] Thada S, Valluri VL, Gaddam SL. Influence of Toll-like receptor gene polymorphisms to tuberculosis susceptibility in humans. Scand J Immunol, 2013, 78(3): 221-229.
[4] de la Barrera S, Aleman M, Musella R, et al. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin Exp Immunol, 2004, 138(1): 128-138.
[5] Garg A, Barnes PF, Roy S, et al. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol, 2008, 38(2): 459-469.
[6] Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol, 2010, 8(4): 296-307.
[7] Lee J, Remold HG, Ieong MH, et al. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol, 2006, 176(7): 4267-4274.
[8] Basu SK, Kumar D, Ganquly N, et al. Mycobacterium tuberculosis secreted antigen (MTSA-10) inhibits macrophage response to lipopolysaccharide by redox regulation of phosphatases. Indian J Exp Biol, 2009, 47(6): 505-519.
[9] Bunt SK, Yang L, Sinha P, et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Caneer Res, 2007, 67(20): 10019-10026.
[10] 杨勐航, 臧远胜, 李兵. 肺癌新生血管生成机制研究进展. 第二军医大学学报, 2013, 34(4): 434-439.
[11] 张韵, 宗文宏, 丁明东, 等. 血清和胸水中MCP-1、MSP、LEP在肺癌及肺结核鉴别中的应用价值. 疑难病杂志, 2016, 15(9): 900-903.
[12] 王达安, 程少冰, 卢康荣. 肺癌患者血清单核细胞趋化蛋白-1含量和活性的变化及意义. 中国老年病学, 2010, 30(14): 1946-1947.
[13] 马克骥. 进展期非小细胞肺癌患者外周血中髓源性抑制细胞比例的测定及其临床意义. 沈阳: 中国医科大学, 2013.
[14] 高绪胜. 老年肺结核免疫治疗研究进展. 实用老年医学, 2015, 29(7): 534-536.
[15] 段静, 候超, 毛源. 老年与青年肺结核患者免疫功能差异的探讨. 实用老年医学, 2014, 29(11): 937-940.
[16] Ca?atay T, Kiran B, Yurt S, et al. Levels of tumor necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis. Respirology, 2005, 10(3): 290-294.
[17] Shahemabadi AS, Hosseini AZ, Shaghsempour S, et al. Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens. Clin Exp Immunol, 2007, 149(2): 285-294. |